SCHEMBL29960469

SCHEMBL29960469

O=C(O)C1CCc2cccc3c2C1CCO3

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
MAP3K14 Q99558 1/20 0.43
SLC9A1 P19634 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MTNR1A P48039 4/20 0.34
MTNR1B P49286 4/20 0.34
PARP1 P09874 1/20 0.33
FABP3 P05413 1/20 0.33
FABP4 P15090 1/20 0.33
OPRL1 P41146 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
ABCB11 O95342 1/20 0.33
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960523 0.80 TSHR (0.43) MAP3K14KDM4EMTNR1AMTNR1B
SCHEMBL10836336 0.80 CYP1A2 (0.45) CYP1A2CYP2D6CYP2C9CYP2C19HIF1A
SCHEMBL16547283 0.75 MAP3K14 (0.41) MAP3K14
Hydrochloric Acid SCHEMBL29960378 0.73 MAP3K14 (0.42) MAP3K14
SCHEMBL13035445 0.68 MAP3K14 (0.40) MAP3K14MTNR1AMTNR1B
SCHEMBL8576142 0.67 FFAR2 (0.45)
SCHEMBL8580943 0.67 FFAR2 (0.45)
SCHEMBL1519203 0.67 FFAR2 (0.45)
SCHEMBL31166527 0.66 SLC9A1 (0.68) SLC9A1MTNR1B
SCHEMBL15805074 0.66 SLC9A1 (0.68) SLC9A1MTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed